糖尿病治療及び診断の世界市場:販売動向2018

【英語タイトル】Global Diabetes Therapeutics and Diagnostics Sales Market Report 2018

QYResearchが出版した調査資料(QYR80704492)・商品コード:QYR80704492
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:121
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、糖尿病治療及び診断の世界市場について調査・分析し、糖尿病治療及び診断のメーカー別販売量、市場シェア分析、種類別販売分析(インスリン、インスリン放出、経口血糖降下薬、診断・モニタリング、その他)、用途別販売分析(1型糖尿病、2型糖尿病、妊娠糖尿病、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、糖尿病治療及び診断産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・糖尿病治療及び診断市場概要
・糖尿病治療及び診断のメーカー別販売量・メーカー別シェア
・糖尿病治療及び診断の世界市場:種類別販売量(インスリン、インスリン放出、経口血糖降下薬、診断・モニタリング、その他)
・糖尿病治療及び診断の世界市場:用途別販売量(1型糖尿病、2型糖尿病、妊娠糖尿病、その他)
・糖尿病治療及び診断の世界市場:地域別販売量・市場シェア
・糖尿病治療及び診断の米国市場規模
・糖尿病治療及び診断の中国市場規模
・糖尿病治療及び診断の欧州市場規模
・糖尿病治療及び診断の日本市場規模
・糖尿病治療及び診断の東南アジア市場規模
・糖尿病治療及び診断のインド市場規模
・糖尿病治療及び診断のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・糖尿病治療及び診断のコスト分析・価格動向
・糖尿病治療及び診断の産業チェーン(サプライチェーン分析)
・糖尿病治療及び診断のマーケティング戦略・販売チャネル、流通業者
・糖尿病治療及び診断市場への影響要因分析
・糖尿病治療及び診断の世界市場予測
・糖尿病治療及び診断の米国市場予測
・糖尿病治療及び診断の中国市場予測
・糖尿病治療及び診断の欧州市場予測
・糖尿病治療及び診断の日本市場予測
・糖尿病治療及び診断の東南アジア市場予測
・糖尿病治療及び診断のインド市場予測
・糖尿病治療及び診断の種類別世界市場予測(インスリン、インスリン放出、経口血糖降下薬、診断・モニタリング、その他)
・糖尿病治療及び診断の用途別世界市場予測(1型糖尿病、2型糖尿病、妊娠糖尿病、その他)
...
【レポートの概要】

This report studies the global Diabetes Therapeutics and Diagnostics market status and forecast, categorizes the global Diabetes Therapeutics and Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
The global Diabetes Therapeutics and Diagnostics market is valued at 128000 million US$ in 2017 and will reach 180600 million US$ by the end of 2025, growing at a CAGR of 4.4% during 2018-2025.

The major players covered in this report
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others

The study objectives of this report are:
To analyze and study the global Diabetes Therapeutics and Diagnostics sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Diabetes Therapeutics and Diagnostics players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Diabetes Therapeutics and Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Diabetes Therapeutics and Diagnostics Manufacturers
Diabetes Therapeutics and Diagnostics Distributors/Traders/Wholesalers
Diabetes Therapeutics and Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Diabetes Therapeutics and Diagnostics market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Diabetes Therapeutics and Diagnostics Sales Market Report 2018
1 Diabetes Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Diabetes Therapeutics and Diagnostics
1.2 Classification of Diabetes Therapeutics and Diagnostics by Product Category
1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Diabetes Therapeutics and Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Insulin
1.2.4 Insulin Delivery
1.2.5 Oral Hypoglycemic Drugs
1.2.6 Diagnosis And Monitoring
1.2.7 Others
1.3 Global Diabetes Therapeutics and Diagnostics Market by Application/End Users
1.3.1 Global Diabetes Therapeutics and Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Type 1 Diabetes
1.3.2 Type 2 Diabetes
1.3.3 Gestational Diabetes
1.3.4 Others
1.4 Global Diabetes Therapeutics and Diagnostics Market by Region
1.4.1 Global Diabetes Therapeutics and Diagnostics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.3 Europe Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.4 China Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.5 Japan Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.7 India Diabetes Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Diabetes Therapeutics and Diagnostics (2013-2025)
1.5.1 Global Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2025)
1.5.2 Global Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2025)

2 Global Diabetes Therapeutics and Diagnostics Competition by Players/Suppliers, Type and Application
2.1 Global Diabetes Therapeutics and Diagnostics Market Competition by Players/Suppliers
2.1.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Diabetes Therapeutics and Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Diabetes Therapeutics and Diagnostics (Volume and Value) by Type
2.2.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
2.2.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
2.3 Global Diabetes Therapeutics and Diagnostics (Volume and Value) by Region
2.3.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Region (2013-2018)
2.3.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Region (2013-2018)
2.4 Global Diabetes Therapeutics and Diagnostics (Volume) by Application

3 United States Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
3.1 United States Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
3.1.1 United States Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
3.1.2 United States Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
3.1.3 United States Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
3.2 United States Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

4 Europe Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
4.1 Europe Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
4.1.1 Europe Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.1.2 Europe Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
4.2 Europe Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

5 China Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
5.1 China Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
5.1.1 China Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.1.2 China Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5.1.3 China Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
5.2 China Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
5.3 China Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
5.4 China Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

6 Japan Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
6.1 Japan Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
6.1.1 Japan Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.1.2 Japan Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
6.2 Japan Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
7.1 Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
7.1.1 Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
7.2 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

8 India Diabetes Therapeutics and Diagnostics (Volume, Value and Sales Price)
8.1 India Diabetes Therapeutics and Diagnostics Sales and Value (2013-2018)
8.1.1 India Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.1.2 India Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8.1.3 India Diabetes Therapeutics and Diagnostics Sales Price Trend (2013-2018)
8.2 India Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Players (2013-2018)
8.3 India Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Type (2013-2018)
8.4 India Diabetes Therapeutics and Diagnostics Sales Volume and Market Share by Application (2013-2018)

9 Global Diabetes Therapeutics and Diagnostics Players/Suppliers Profiles and Sales Data
9.1 77 Elektronika Kft.
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 A. Menarini Diagnostics S.R.L
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Abbott Laboratories
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Agamatrix Inc.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Animas Corp.
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Ascensia
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Ascensia Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Becton Dickinson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Debiotech S.A.
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Eli Lilly And Co.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Glaxo Smithkline
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Diabetes Therapeutics and Diagnostics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Inlight Solutions Inc.
9.12 Johnson & Johnson
9.13 Lifescan Inc.
9.14 Medtronic
9.15 Merck & Co.
9.16 Merck KGAA
9.17 Nipro Corp.
9.18 Novartis Pharma Ag
9.19 Novo Nordisk A/S
9.20 Owen Mumford Ltd.
9.21 Palco Labs Inc.
9.22 Roche
9.23 Sanofi
9.24 Takeda Pharmaceutical Co. Ltd.
9.25 Terumo Corp.

10 Diabetes Therapeutics and Diagnostics Maufacturing Cost Analysis
10.1 Diabetes Therapeutics and Diagnostics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Diabetes Therapeutics and Diagnostics
10.3 Manufacturing Process Analysis of Diabetes Therapeutics and Diagnostics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Diabetes Therapeutics and Diagnostics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Diabetes Therapeutics and Diagnostics Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Diabetes Therapeutics and Diagnostics Market Forecast (2018-2025)
14.1 Global Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Diabetes Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Diabetes Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Diabetes Therapeutics and Diagnostics Price and Trend Forecast (2018-2025)
14.2 Global Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Diabetes Therapeutics and Diagnostics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Diabetes Therapeutics and Diagnostics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Diabetes Therapeutics and Diagnostics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type (2018-2025)
14.3.2 Global Diabetes Therapeutics and Diagnostics Revenue Forecast by Type (2018-2025)
14.3.3 Global Diabetes Therapeutics and Diagnostics Price Forecast by Type (2018-2025)
14.4 Global Diabetes Therapeutics and Diagnostics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Diabetes Therapeutics and Diagnostics
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (Product Category) in 2017
Figure Insulin Product Picture
Figure Insulin Delivery Product Picture
Figure Oral Hypoglycemic Drugs Product Picture
Figure Diagnosis And Monitoring Product Picture
Figure Others Product Picture
Figure Global Diabetes Therapeutics and Diagnostics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Diabetes Therapeutics and Diagnostics by Application in 2017
Figure Type 1 Diabetes Examples
Table Key Downstream Customer in Type 1 Diabetes
Figure Type 2 Diabetes Examples
Table Key Downstream Customer in Type 2 Diabetes
Figure Gestational Diabetes Examples
Table Key Downstream Customer in Gestational Diabetes
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Diabetes Therapeutics and Diagnostics Market Size (Million USD) by Regions (2013-2025)
Figure United States Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Diabetes Therapeutics and Diagnostics Sales Volume (K Units) (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Diabetes Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure 2017 Diabetes Therapeutics and Diagnostics Sales Share by Players/Suppliers
Figure Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Diabetes Therapeutics and Diagnostics Revenue Share by Players
Table 2017 Global Diabetes Therapeutics and Diagnostics Revenue Share by Players
Table Global Diabetes Therapeutics and Diagnostics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Diabetes Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Sales Growth Rate by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Diabetes Therapeutics and Diagnostics by Type (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Growth Rate by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share by Region (2013-2018)
Figure Sales Market Share of Diabetes Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Sales Growth Rate by Region in 2017
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Diabetes Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Growth Rate by Region in 2017
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Diabetes Therapeutics and Diagnostics by Region (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Region in 2017
Table Global Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Diabetes Therapeutics and Diagnostics by Application (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table United States Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table United States Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure United States Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Europe Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure China Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure China Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table China Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table China Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table China Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure China Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Japan Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Figure India Diabetes Therapeutics and Diagnostics Sales (K Units) and Growth Rate (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Sales Price (USD/Unit) Trend (2013-2018)
Table India Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Players (2013-2018)
Table India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Players in 2017
Table India Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Type (2013-2018)
Table India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Type in 2017
Table India Diabetes Therapeutics and Diagnostics Sales Volume (K Units) by Application (2013-2018)
Table India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Sales Volume Market Share by Application in 2017
Table 77 Elektronika Kft. Basic Information List
Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table A. Menarini Diagnostics S.R.L Basic Information List
Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Agamatrix Inc. Basic Information List
Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Animas Corp. Basic Information List
Table Animas Corp. Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Animas Corp. Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Animas Corp. Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Animas Corp. Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Ascensia Basic Information List
Table Ascensia Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ascensia Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Ascensia Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Ascensia Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Becton Dickinson Basic Information List
Table Becton Dickinson Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Becton Dickinson Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Becton Dickinson Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Debiotech S.A. Basic Information List
Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018
Figure Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Eli Lilly And Co. Basic Information List
Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Glaxo Smithkline Basic Information List
Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales Growth Rate (2013-2018)
Figure Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales Global Market Share (2013-2018)
Figure Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue Global Market Share (2013-2018)
Table Inlight Solutions Inc. Basic Information List
Table Johnson & Johnson Basic Information List
Table Lifescan Inc. Basic Information List
Table Medtronic Basic Information List
Table Merck & Co. Basic Information List
Table Merck KGAA Basic Information List
Table Nipro Corp. Basic Information List
Table Novartis Pharma Ag Basic Information List
Table Novo Nordisk A/S Basic Information List
Table Owen Mumford Ltd. Basic Information List
Table Palco Labs Inc. Basic Information List
Table Roche Basic Information List
Table Sanofi Basic Information List
Table Takeda Pharmaceutical Co. Ltd. Basic Information List
Table Terumo Corp. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diabetes Therapeutics and Diagnostics
Figure Manufacturing Process Analysis of Diabetes Therapeutics and Diagnostics
Figure Diabetes Therapeutics and Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Diabetes Therapeutics and Diagnostics Major Players in 2017
Table Major Buyers of Diabetes Therapeutics and Diagnostics
Table Distributors/Traders List
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Diabetes Therapeutics and Diagnostics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume Market Share Forecast by Regions in 2025
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share Forecast by Regions in 2025
Figure United States Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Diabetes Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2018-2025)
Figure China Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Diabetes Therapeutics and Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Diabetes Therapeutics and Diagnostics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Diabetes Therapeutics and Diagnostics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Diabetes Therapeutics and Diagnostics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share Forecast by Type (2018-2025)
Table Global Diabetes Therapeutics and Diagnostics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Diabetes Therapeutics and Diagnostics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

糖尿病治療及び診断、インスリン、インスリン放出、経口血糖降下薬、診断・モニタリング、1型糖尿病、2型糖尿病、妊娠糖尿病

★調査レポート[糖尿病治療及び診断の世界市場:販売動向2018] (コード:QYR80704492)販売に関する免責事項を必ずご確認ください。
★調査レポート[糖尿病治療及び診断の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆